JP6309980B2 - 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法 - Google Patents

抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法 Download PDF

Info

Publication number
JP6309980B2
JP6309980B2 JP2015559259A JP2015559259A JP6309980B2 JP 6309980 B2 JP6309980 B2 JP 6309980B2 JP 2015559259 A JP2015559259 A JP 2015559259A JP 2015559259 A JP2015559259 A JP 2015559259A JP 6309980 B2 JP6309980 B2 JP 6309980B2
Authority
JP
Japan
Prior art keywords
npc
therapeutic agent
biofilm
pharmaceutical composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015559259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509067A (ja
JP2016509067A5 (https=
Inventor
ク ヒョン
ク ヒョン
ブノワ ダニエル
ブノワ ダニエル
アイ．クレイン マーリース
アイ．クレイン マーリース
エル．フォールセッタ ウッド ミーガン
エル．フォールセッタ ウッド ミーガン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of JP2016509067A publication Critical patent/JP2016509067A/ja
Publication of JP2016509067A5 publication Critical patent/JP2016509067A5/ja
Application granted granted Critical
Publication of JP6309980B2 publication Critical patent/JP6309980B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015559259A 2013-02-25 2014-02-25 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法 Expired - Fee Related JP6309980B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361768929P 2013-02-25 2013-02-25
US61/768,929 2013-02-25
PCT/US2014/018211 WO2014130994A1 (en) 2013-02-25 2014-02-25 Nanoparticles for controlled release of anti-biofilm agents

Publications (3)

Publication Number Publication Date
JP2016509067A JP2016509067A (ja) 2016-03-24
JP2016509067A5 JP2016509067A5 (https=) 2017-03-30
JP6309980B2 true JP6309980B2 (ja) 2018-04-11

Family

ID=51391907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015559259A Expired - Fee Related JP6309980B2 (ja) 2013-02-25 2014-02-25 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法

Country Status (7)

Country Link
US (1) US9566247B2 (https=)
EP (1) EP2958557B1 (https=)
JP (1) JP6309980B2 (https=)
CN (1) CN105142620B (https=)
AU (1) AU2014218569B2 (https=)
CA (1) CA2902157A1 (https=)
WO (1) WO2014130994A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
CN107406556B (zh) * 2015-03-04 2020-07-17 陶氏环球技术有限责任公司 作为用于不良水溶性物质从固体混合物有效增溶的赋形剂的共聚物
WO2017070578A1 (en) 2015-10-21 2017-04-27 The Regents Of The University Of Michigan Detection and treatment of caries and microcavities with nanoparticles
WO2017176796A1 (en) 2016-04-04 2017-10-12 University Of Virginia Patent Foundation Compositions and methods for preventing and treating disease
US20210330599A1 (en) * 2016-08-01 2021-10-28 University Of Rochester Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
CN106370636B (zh) * 2016-08-31 2019-02-26 中国科学院新疆生态与地理研究所 一种检测生物膜表面吸附纳米颗粒的方法
EP3585351A4 (en) * 2017-02-23 2020-12-30 Alira Health Boston LLC ECOPHILIC ANTIMICROBIAL FORMULATIONS DISRUPTING BIOFILMS, THEIR DEVELOPMENT AND THEIR USES
BR112019018084A2 (pt) * 2017-03-03 2020-03-24 The Procter & Gamble Company Métodos para quantificar íons em um biofilme dental
EP3612570A4 (en) * 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
US11291613B2 (en) 2017-05-16 2022-04-05 Johnson & Johnson Consumer Inc. Coated particles and their uses
DE102017130893A1 (de) * 2017-12-21 2019-06-27 Paul Hartmann Ag pH regulierende Wundauflage
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3847442A4 (en) 2018-09-06 2022-10-12 GreenMark Biomedical Inc. SYSTEM FOR TOOTH IMAGING AND/OR HARDENING
CN109091453A (zh) * 2018-09-18 2018-12-28 成都爱睿康美医疗科技有限责任公司 葡萄糖响应性的可注射纳米凝胶及其制备方法和应用
CN113226379A (zh) * 2018-10-22 2021-08-06 武田药品工业株式会社 靶向内体中g蛋白偶联受体的纳米颗粒封装
CN109827814A (zh) * 2019-03-11 2019-05-31 南京大学 一种新型大气颗粒物琼脂采样膜制备及免溶剂提取细胞暴露方法
WO2020198468A1 (en) * 2019-03-26 2020-10-01 Temple University-Of The Commonwealth System Of Higher Education Smart composite with antibiofilm, mineralizing, and antiinfection therapeutic effects
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
DE102019122569A1 (de) 2019-08-22 2021-02-25 Mühlbauer Technology Gmbh Flavonoidderivat
US12509559B2 (en) 2019-10-28 2025-12-30 Brown University Bacterial beta-lactamase responsive hydrogels
US20210179884A1 (en) 2019-12-17 2021-06-17 Columbia Insurance Company Redox chased suspension bead additives for paints and stains
CN116887866A (zh) 2020-12-03 2023-10-13 巴特尔纪念研究院 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
WO2023091676A1 (en) * 2021-11-19 2023-05-25 The Regents Of The University Of Michigan Biofilm-targeting nanoparticles to increase the anticaries effect of fluoride
EP4543993A1 (en) 2022-07-11 2025-04-30 Benjamin Moore & Co. Nonionic resins, and mixtures of nonionic resins with cationic additives for stain blocking architectural compositions
CN115671264B (zh) * 2023-01-04 2023-03-07 云南伦扬科技有限公司 一种用于靶向光催化变形链球菌生物膜的级联纳米酶
WO2024226999A1 (en) * 2023-04-28 2024-10-31 Brown University Methods of making and using nanoparticles for treatment of microbial biofilms
CN116570734B (zh) * 2023-07-13 2023-10-13 四川大学华西医院 一种具有靶向功能的核壳壳结构药物胶束及其制备方法
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
US12441996B2 (en) 2023-12-08 2025-10-14 Battelle Memorial Institute Use of DNA origami nanostructures for molecular information based data storage systems
CN118955827B (zh) * 2024-07-31 2025-09-12 安徽农业大学 一种纳米载体及其制备方法和应用
CN120324589B (zh) * 2025-04-17 2026-03-27 陕西佰济生物研发有限公司 一种响应式释放微胶囊及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116602A (en) * 1989-09-27 1992-05-26 Colgate-Palmolive Company Antiplaque oral compositions
BRPI0314042B8 (pt) * 2002-09-06 2021-05-25 Calando Pharmaceuticals Inc polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
WO2005030174A1 (en) 2003-09-23 2005-04-07 Massachusetts Institute Of Technology Ph-triggered microparticles
CA2605551A1 (en) * 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering rnaiii-inhibiting peptides
US8119162B2 (en) * 2005-11-10 2012-02-21 Colgate-Palmolive Company Particles that disrupt or impede bacterial adhesion, related compositions and methods
NZ569756A (en) 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
US20100021391A1 (en) * 2006-07-14 2010-01-28 Montana State University Novel nanoparticles for biofilm targeting
US8188068B2 (en) 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
KR101764427B1 (ko) 2008-05-13 2017-08-02 유니버시티 오브 워싱톤 미셀성 어셈블리
EP2313101A4 (en) * 2008-07-09 2014-05-21 Univ Nebraska FUNCTIONAL MICELLES FOR HARD FIBER-RELATED CHEMICAL RELEASE RELEASE
EP2335073A4 (en) * 2008-09-02 2012-09-26 Univ Maryland DIAGNOSIS OF BIOFILM IN VIVO INFECTION AND TREATMENT
US9089677B2 (en) 2011-01-25 2015-07-28 The Regents Of The University Of California Transcutaneous multimodal delivery system (TMDS)

Also Published As

Publication number Publication date
CN105142620B (zh) 2018-09-28
CN105142620A (zh) 2015-12-09
WO2014130994A1 (en) 2014-08-28
JP2016509067A (ja) 2016-03-24
EP2958557B1 (en) 2019-11-27
EP2958557A4 (en) 2016-11-30
AU2014218569B2 (en) 2018-10-04
EP2958557A1 (en) 2015-12-30
CA2902157A1 (en) 2014-08-28
US20150374634A1 (en) 2015-12-31
AU2014218569A1 (en) 2015-10-15
US9566247B2 (en) 2017-02-14

Similar Documents

Publication Publication Date Title
JP6309980B2 (ja) 抗バイオフィルム剤を制御放出するためのナノ粒子及びその使用方法
US20210330599A1 (en) Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
Xi et al. Dual corona vesicles with intrinsic antibacterial and enhanced antibiotic delivery capabilities for effective treatment of biofilm-induced periodontitis
Horev et al. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence
Meng et al. An overview of chitosan and its application in infectious diseases
Maghsoudi et al. Curcumin-loaded polysaccharide nanoparticles: Optimization and anticariogenic activity against Streptococcus mutans
Mintzer et al. Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases
JP5771143B2 (ja) 硬組織に標的化された化学物質送達用の機能的ミセル
EP2872120B1 (en) Therapeutic nanoparticles with a polymyxin b as targeting agent
Yang et al. Antibacterial activity of nitric oxide-releasing hyperbranched polyamidoamines
US8153617B2 (en) Bridged polycyclic compound based compositions for coating oral surfaces in humans
AU2008218275B2 (en) Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
CN107708709A (zh) 铁氧化物纳米粒子及其使用方法
Chifiriuc et al. Antibiotic drug delivery systems for the intracellular targeting of bacterial pathogens
Engin et al. Nanoantibiotics: A novel rational approach to antibiotic resistant infections
CN107708757A (zh) 用于不利地影响生物膜的方法
JP2019513837A (ja) フィトグリコーゲンナノ粒子を含む抗感染症組成物
US9694085B2 (en) Targeted therapeutic nanoparticles
Ramamurthy et al. Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applications
Xin et al. Oral environment-adaptive peptide–polymer conjugate for caries prevention with targeting, antibacterial, and antifouling abilities
He et al. Development of “Intelligent particles” for the treatment of dental caries
Kumawat et al. pH-responsive, reactive oxygen species scavenging and highly swellable nanogel for colon-targeted oral drug delivery
Dai et al. Protonation–activity relationship of bioinspired ionizable glycomimetics for the growth Inhibition of bacteria
Romanovska Synthesis of amphiphilic antimicrobial polymer-antibiotic conjugates and particle networks
Alsalami et al. Natural And Synthetic Drug Polymers

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180131

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180315

R150 Certificate of patent or registration of utility model

Ref document number: 6309980

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees